Fingolimod, another BDNF mimetic that can stimulate BDNF expression, ameliorates symptoms in Mecp2 KO mice (Bird line) (Deogracias et al., 2012), although its effectiveness in treating RTT patients was recently shown to be limited (Naegelin et al., 2021). The gene discussed is BDNF; the disease is Rett syndrome.